TOSI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.870
EU - Europa 10.259
AS - Asia 2.353
SA - Sud America 35
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 14
Totale 29.572
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.812
GB - Regno Unito 3.913
IT - Italia 2.874
SE - Svezia 1.168
CN - Cina 834
HK - Hong Kong 681
DE - Germania 608
UA - Ucraina 517
TR - Turchia 516
FI - Finlandia 322
FR - Francia 224
BG - Bulgaria 215
IN - India 79
BE - Belgio 65
IE - Irlanda 58
RO - Romania 58
RU - Federazione Russa 56
KR - Corea 44
CA - Canada 39
ES - Italia 38
NL - Olanda 36
IR - Iran 33
CH - Svizzera 31
IL - Israele 29
VN - Vietnam 27
MY - Malesia 22
SG - Singapore 19
JP - Giappone 18
GR - Grecia 17
PL - Polonia 15
BD - Bangladesh 14
EU - Europa 14
BR - Brasile 13
MX - Messico 12
PT - Portogallo 11
AU - Australia 9
TW - Taiwan 9
CL - Cile 8
CZ - Repubblica Ceca 7
EG - Egitto 7
ID - Indonesia 7
SN - Senegal 7
AR - Argentina 6
HU - Ungheria 6
BZ - Belize 5
IQ - Iraq 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
ZA - Sudafrica 5
AT - Austria 4
CO - Colombia 4
DK - Danimarca 4
LT - Lituania 3
MA - Marocco 3
YE - Yemen 3
AN - Antille olandesi 2
BY - Bielorussia 2
DZ - Algeria 2
EC - Ecuador 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
PE - Perù 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 29.572
Salva come PNG Salva come JPEG
Città #
Southend 3.452
Fairfield 2.220
Chandler 1.670
Woodbridge 1.618
Ashburn 1.236
Jacksonville 1.135
Houston 976
Seattle 943
Dearborn 875
Wilmington 863
Ann Arbor 776
Nyköping 761
Cambridge 747
Hong Kong 661
Modena 492
Beijing 344
Izmir 324
Princeton 235
Sofia 211
Eugene 200
San Diego 197
New York 158
Milan 135
Helsinki 134
Redwood City 121
Rome 98
London 94
Bremen 93
Falls Church 93
Bologna 87
Des Moines 83
Fremont 83
Brussels 59
Parma 51
Florence 47
Shanghai 45
Dublin 44
Hefei 41
Reggio Emilia 40
Como 39
Tulare 39
Napoli 37
Norwalk 37
Nanjing 36
Boardman 31
Kunming 29
Bari 26
Naples 26
San Giuliano Milanese 25
Padova 23
Palermo 22
Los Angeles 21
Catania 20
Dong Ket 20
Hounslow 19
Turin 19
Mountain View 18
Jinan 16
Kocaeli 16
Verona 16
Central 15
Genoa 15
Indiana 15
Kilburn 15
Washington 15
Phoenix 14
Prescot 14
Saint Petersburg 14
Perugia 13
Guangzhou 12
Halifax 12
Istanbul 12
Rende 12
Chicago 11
Dongguan 11
Ferrara 11
Limerick 11
Zhengzhou 11
Auburn Hills 10
Barcelona 10
Carmichael 10
Chiswick 10
San Mateo 10
Chennai 9
Giv‘atayim 9
Paris 9
Pescara 9
Reggio Nell'emilia 9
Wuhan 9
Brescia 8
Chieti 8
Chongqing 8
Roseto degli Abruzzi 8
Salerno 8
Sassuolo 8
Tokyo 8
Castelnuovo Di Porto 7
Dakar 7
Formigine 7
Fuzhou 7
Totale 22.398
Salva come PNG Salva come JPEG
Nome #
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 345
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 292
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 276
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 268
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 258
Protein corona and nanoparticles: How can we investigate on? 243
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 236
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 234
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 230
Nanoparticle transport across the blood brain barrier 227
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 224
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 224
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 222
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 222
Advances and perspectives for Central Nervous System drug delivery: the interface between nanotechnology and neuroscience 219
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 219
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 217
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 217
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 213
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 209
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 208
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 207
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 206
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 206
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 203
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 201
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 199
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 199
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 199
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 198
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 198
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 195
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 192
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 191
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 190
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 186
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 186
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 185
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 185
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 185
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 184
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 184
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 182
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 181
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 180
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 180
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 180
Colloidal systems for CNS drug delivery 179
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 179
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 179
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 178
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 177
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 177
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 176
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 175
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 174
Functionalization of liposomes: microscopical methods for preformulative screening 174
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 174
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 172
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 172
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 169
Chemo-enzymatic synthesis of levodropropizine 169
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 168
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 167
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 167
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 167
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 167
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 166
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 165
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 164
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 164
Detection of PLGA-based nanoparticles at single cell level by Synchrotron Radiation FTIR Spectromicroscopy and correlation with X-Ray Fluorescence Microscopy 164
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 162
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 162
Polymeric nanoparticles for the drug delivery to the central nervous system 160
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 158
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 158
Brain targeting with polymeric nanoparticles: which administration route should we take? 158
Ketorolac tromethamine liposomes: Encapsulation and release studies 156
Emerging use of nanotechnology in the treatment of neurological disorders 156
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 156
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 155
Nanomedicine and neurodegenerative disorders: So close yet so far 154
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 154
Nanomedicine: the future for advancing medicine and neuroscience 152
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 150
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 150
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 149
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. 148
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 147
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 146
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 145
Intact collagen and atelocollagen sponges: Characterization and ESEM observation 145
Sintesi Asimmetrica Biocatalitica di (S)-(–)-Timolo 143
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 143
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 143
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 142
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 142
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 140
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 139
Totale 18.481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.075
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.443 0 0 0 0 0 0 0 0 0 0 704 739
2019/20206.510 360 377 162 396 755 858 1.071 715 917 242 411 246
2020/20215.468 750 238 420 501 461 353 459 655 255 834 313 229
2021/20224.031 178 482 379 242 154 210 213 222 483 320 642 506
2022/20234.655 577 548 362 472 544 622 125 411 528 74 190 202
2023/20243.054 165 197 221 285 793 356 401 418 109 107 2 0
Totale 29.956